Market Overview

UPDATE: Jefferies Downgrades Pfizer on Challenges Ahead

Share:

In a report published Friday, Jefferies analyst Jeffrey Holford downgraded the rating on Pfizer (NYSE: PFE) from Buy to Hold, and lowered the price target from $32.00 to $30.00.

In the report, Jefferies noted, “Rising rate expectations had the expected impact on the sector, which has been driven by income investors over the past two years. Q2'13 earnings look tough in this context and we expect most companies to see some pressure. Novartis, Sanofi, Roche, Abbott, AbbVie and Bayer remain high conviction Buy ideas. We have downgraded Bristol-Myers and Pfizer to Hold in this report as part of our update today.”

Pfizer closed on Thursday at $28.44.

Latest Ratings for PFE

DateFirmActionFromTo
Aug 2019UpgradesSellHold
Aug 2019MaintainsEqual-Weight
Jul 2019DowngradesBuyNeutral

View More Analyst Ratings for PFE
View the Latest Analyst Ratings

Posted-In: Jefferies Jeffrey HolfordAnalyst Color Downgrades Analyst Ratings

 

Related Articles (PFE)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
NFEMorgan StanleyReinstates25.0
ACBMKM PartnersInitiates Coverage On5.0
STZMorgan StanleyMaintains227.0
CQPMorgan StanleyReinstates42.0
LNGMorgan StanleyReinstates74.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

UPDATE: Jefferies Lowers PT on Zoetis on Challenges Ahead

How to Make Sense of This Ridiculous Market Situation